grey market retatrutide price Cheap and risky: Stung by high prices, Americans turn to DIY weight-loss drugs from the Retatrutide Cost Breakdown: Monthly Estimates

Thats become common because GLP-1 drugs are expensive for health plans and the employers that pay for them

The Market The global GLP-1 market is exploding In 2023, global spending on GLP-1s represented $6 billion in value

The FDA announces deadlines: Compounding tirzepatide: immediate stop for state-licensed pharmacies, deadline of March 19, 2025 for larger outsourcing facilities

Despite widespread demand, affordability and insurance coverage lag far behind medical efficacy

A revolution in the treatment of obesity

Patients should contact their healthcare provider if diarrhea persists beyond 2-4 weeks after reaching a stable dose, as this may indicate inadequate tolerance or an alternative underlying condition requiring investigation